Board of Directors

Robert Coggin is Executive Vice President and Vice Chairman of the Travel Distribution Services division of Cendant Corp. and the former EVP marketing for Delta Airlines. Mr. Coggin has also consulted with large businesses including Priceline.com, The Bahamas Ministry of Tourism, Flightservice.com, and World Airways.

During his 42-year career with Delta, Mr. Coggin served in various capacities in Delta’s Passenger Service and Sales/Marketing Divisions. As Executive Vice President of Marketing, he was one of four members of Delta’s Executive Council and participated in decision making and the formation of policy related to issues such as aircraft acquisition, mergers and acquisitions, expansion, technology, human resources, finance and accounting and alliances.

Roberto Estrada founded HolaDoctor in 1999. His current responsibilities include overseeing the company, chairing the Board of Directors, leading relationships with investors and supervising the senior executives. From 1999 to the present, Mr. Estrada established and successfully grew an internet-based company through a very challenging and unpredictable period in the market.

From 1996-1999, he was President of Penta Resources, Inc., an export company involved in the Latin American paper and paint industries. From 1994-1996, Mr. Estrada was Vice President of Export Sales for Polar Minerals responsible for sales and marketing functions in all countries in Latin America. Prior to that, he held various positions at ECC International, most recently as Latin American Sales Manager.

Mr. Estrada is a native of Nicaragua and has traveled extensively throughout Latin America over the last twenty years. He has conducted business in most Latin American countries. Mr. Estrada received a BS in Chemical Engineering from Christian Brothers University in 1987 after which he received an MBA from Vanderbilt University in 1989.

Ms. Dean joined HolaDoctor in October of 2008 with 20 years of Healthcare technology and operations experience. Previously, Ms. Dean was Executive Vice President and Chief Technology Officer for Matria Healthcare Inc. In her role at Matria, she was responsible for the Technology Operations, Development, Client Data Processing, Product Management and Informatics Departments.

Joining Matria in 2005, Ms. Dean oversaw the technology that consolidates and integrates Matria’s client data sources. She was instrumental in leading the efforts to implement automation of data flow and pre-profiling of the data feeds to significantly reduce the overall cycle time from data receipt to member access by the counselors and clinicians.

Prior to joining Matria, Debbie was Senior VP of Research and Development for Quovadx, Inc., a leading healthcare integration company. While at Quovadx, she developed the premier eligibility and claims clearinghouse product that integrated the top clearinghouses such as HDX, WebMD, MedUnite, Proxymed and Medifax. Prior thereto, Debbie worked in data warehousing and client informatics reporting management roles with Medstat and Criterion Health Strategies growing small private companies into public entities.

Ms. Dean earned a bachelor’s degree in Health Services Administration from Arkansas State University.

Michael Schaenen is the founder and Managing Partner of Somerset Capital Advisers LLC, a private investment partnership located in New York City. The firm was founded in 1995, following the sale of his previous asset management firm, Schaenen Wood & Associates, to KeyCorp, a national bank holding company. Prior to this he was employed by Oppenheimer & Co. from 1966-1976, where he was involved with portfolio management, investment banking and institutional sales; he served as a general partner of that firm for the final eight years of his employment there. He entered the investment business at Bache & Co. in 1960, where he managed individual portfolios in their Dallas, Texas office until his move to New York.

Over his 50 year career, Mr. Schaenen has served on the boards of several private companies, and has acted in the role of unofficial consultant to several more. His exposure to virtually all facets of the investment industry have given him an unusual grasp of the complexities of business, and he has been able to bring this to bear in working with companies in divergent economic sectors.

As a husband, father of four and grandfather of seven, he spends much of his non-professional time with immediate family. However, he also serves as Vice Chairman of The Children’s Village, a residential care center in Dobbs Ferry, New York, to which he devotes a substantial part of his attention. This organization serves the needs of inner-city children who need to be fed, clothed, educated and prepared for re-entry into their respective communities and he deems this mission to be enormously important on a number of levels.

Mr. Schaenen graduated from Amherst College with a B.A. in Psychology.

Senior Vice President, Business Development and Mergers & Acquisitions LexisNexis Group.

Michael Frankel has served as Senior Vice President, Business Development and Mergers & Acquisitions for LexisNexis Group since January 2008.  He has global responsibility for all corporate development and M&A activities and is based in the New York headquarters.

Michael is a senior strategy and corporate development executive with experience several sectors including market research and data analytics, B2B content and data, enterprise software and consumer finance.  He has deep expertise in acquisitions, equity and venture investing,strategy, product development and international expansion.  He has led initiatives and transactions, deploying over $10B in capital, and driving strategic expansion at several Fortune 500 companies.

Before joining LexisNexis, Michael served as Senior Vice President of Corporate Development and Strategy at Information Resources Inc. (IRI).  Reporting to the CEO and Chairman, Frankel was responsible for all strategic transactions including acquisitions, equity investments, divestitures, strategic partnerships and corporate strategy.

Prior to IRI Michael was Vice President Business Development at GE Capital’s consumer finance group, at VeriSign, as Vice President Corporate Development—where he led one of the ten most acquisitive corporate development teams in the technology sector—and later served as Vice President and General Manager of their Directory Services group. Michael was also Vice President Investment Banking with Merrill Lynch and a Corporate Associate with Skadden, Arps, Slate, Meagher & Flom.

Michael also serves on the advisory board to FortiusOne (a geo-data and visualization company) as well as on the Alumni Board of Governors of the University of Chicago.

During his career Michael has led and closed more than 100 transactions, including acquisitions, divestitures and alliances. In addition, he has authored three books and several articles on M&A.  Michael earned a BA in Political Science, an MA in International Relations, an MBA, and a Juris Doctorate—all from the University of Chicago.

Dr. Schroeder co-founded HolaDoctor in 1999 with Roberto Estrada. His current responsibilities include directing HolaDoctor’s research and consulting services.  Dr. Schroeder is an expert in global health and a former tenured Associate Professor at Emory University’s Rollins School of Public Health. Dr. Schroeder retains a faculty appointment at Emory in the Department of Global Health where he continues to teach.

Prior to Emory, Dr. Schroeder was a post‑doctoral fellow at Cornell University from 1992 to 1993. Between 1989 and 1991, he lived in Guatemala and worked for the Institute of Nutrition of Central America and Panama. Dr. Schroeder has worked throughout Latin America for more than two decades and is fluent in Spanish. He has received numerous honors and awards including a Future Leader Award (International Life Sciences Institute of North America, 1998), Professor of the Year (Emory School of Public Health, 1997), and a Fulbright Fellowship (Indonesia, 1985‑1986).

Dr. Schroeder received his PhD and MPH degrees from Johns Hopkins University in 1992 and a BA with honors and distinction from Stanford University in 1984. Dr. Schroeder is the author of a book and various articles. He has worked in or traveled to over 75 countries.

Tom has been Chief Financial Officer of Envision Pharmaceutical Holdings, Inc. since September 2010.

Prior to joining Envision, Tom was a Partner with Ernst & Young in Cleveland, Ohio from October 1998 through September 2010, where he specialized in mergers & acquisitions, debt and equity financings, restructurings, private equity transactions, growth companies, SEC filings and registration statements.   Tom also has extensive experience with accounting, auditing and internal controls for privately held companies and public companies in a wide range of industries including healthcare, manufacturing, metals and mining, distribution and financial services.

Tom is a CPA and holds an active license in Ohio.

Education:  Bachelor of Science, Accounting, Miami University